Last updated on October 2018

Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age


Brief description of study

This Phase 1b will describe the safety and immunogenicity of 2 multivalent pneumococcal conjugate vaccine formulations in healthy Japanese adults in the United States.

Clinical Study Identifier: NCT03642847

Contact Investigators or Research Sites near you

Start Over

Pfizer CT.gov Call Center

Collaborative Neuroscience Network, LLC. (Study Visits)
Long Beach, CA United States
9.08miles

Pfizer CT.gov Call Center

Collaborative Neuroscience Network, LLC. - (Study Visits & IP Shipment/Storage)
Long Beach, CA United States
9.08miles

Pfizer CT.gov Call Center

Collaborative Neuroscience Network, LLC. - Investigator Site File Location (Regulatory)
Garden Grove, CA United States
9.1miles